Skip to main content
Top
Published in: Journal of Neurology 11/2020

01-11-2020 | Magnetic Resonance Imaging | Original Communication

Clinico-radiological dissociation of disease activity in MS patients: frequency and clinical relevance

Authors: Nina L. van Faals, Iris Dekker, Lisanne J. Balk, Bastiaan Moraal, Frederik Barkhof, Bernard M. J. Uitdehaag, Joep Killestein, Mike P. Wattjes

Published in: Journal of Neurology | Issue 11/2020

Login to get access

Abstract

Objective

To investigate the prevalence and clinical relevance regarding disability progression in multiple sclerosis patients with a dissociation in clinical and radiological disease expression.

Methods

We prospectively selected patients with early relapsing–remitting multiple sclerosis (MS) or a clinically isolated syndrome (CIS) from the Amsterdam MS cohort. Patients underwent clinical examination at baseline, after 2 years, 6 years and a subset also after 11 years, including the Expanded Disability Status Scale (EDSS), 25-foot walk test (25-FWT) and 9-hole peg test (9-HPT). Brain and spinal cord MRI scans were obtained at baseline and after 2 years. Two years after baseline, patients with dissociation in their clinical and radiological disease progression were identified as: (1) patients with high clinical disease activity (defined by relapses) and low radiological disease activity (defined by white-matter lesions on T2-weighted imaging); or (2) patients with low clinical disease activity and high radiological disease activity. Binary logistic regression analyses were performed to predict disability progression after 6 and 11 years of follow-up. Patients with low clinical and low radiological disease activity were used as the reference group.

Results

The prevalence of clinico-radiological dissociation was low (6.4% had high clinical and low radiological disease activity and 5.1% had a combination of low clinical and high radiological disease activity) compared to 88.5% of patients without a dissociation. Patients with a dissociation of clinical and radiological disease activity did not show a statistically significant difference in risk of disability progression after 6 and 11 years.

Conclusions

A clinico-radiological dissociation is rather a rare phenomenon in MS patients. The clinical relevance of such a dissociation regarding the prediction of disability progression is questionable.
Literature
1.
go back to reference Wattjes MP, Steenwijk MD, Stangel M (2015) MRI in the diagnosis and monitoring of multiple sclerosis: an update. Clin Neuroradiol 25(Suppl 2):157–165CrossRef Wattjes MP, Steenwijk MD, Stangel M (2015) MRI in the diagnosis and monitoring of multiple sclerosis: an update. Clin Neuroradiol 25(Suppl 2):157–165CrossRef
2.
go back to reference Barkhof F (2002) The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 15:239–245CrossRef Barkhof F (2002) The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 15:239–245CrossRef
3.
go back to reference Reich DS, Lucchinetti CF, Calabresi PA (2018) Multiple sclerosis. N Engl J Med 378:169–180CrossRef Reich DS, Lucchinetti CF, Calabresi PA (2018) Multiple sclerosis. N Engl J Med 378:169–180CrossRef
4.
go back to reference Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58:840–846CrossRef Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58:840–846CrossRef
5.
go back to reference Sombekke MH, Wattjes MP, Balk LJ, Nielsen JM, Vrenken H, Uitdehaag BM et al (2013) Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis. Neurology 80:69–75CrossRef Sombekke MH, Wattjes MP, Balk LJ, Nielsen JM, Vrenken H, Uitdehaag BM et al (2013) Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis. Neurology 80:69–75CrossRef
6.
go back to reference Uitdehaag BMJ (2018) Disability outcome measures in phase III Clinical trials in multiple sclerosis. CNS Drugs 32:543–558CrossRef Uitdehaag BMJ (2018) Disability outcome measures in phase III Clinical trials in multiple sclerosis. CNS Drugs 32:543–558CrossRef
7.
go back to reference Cadavid D, Cohen JA, Freedman MS, Goldman MD, Hartung HP, Havrdova E et al (2017) The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis. Mult Scler 23:94–105CrossRef Cadavid D, Cohen JA, Freedman MS, Goldman MD, Hartung HP, Havrdova E et al (2017) The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis. Mult Scler 23:94–105CrossRef
8.
go back to reference Healy BC, Buckle GJ, Ali EN, Egorova S, Khalid F, Tauhid S et al (2017) Characterizing clinical and mri dissociation in patients with multiple sclerosis. J Neuroimaging 27:481–485CrossRef Healy BC, Buckle GJ, Ali EN, Egorova S, Khalid F, Tauhid S et al (2017) Characterizing clinical and mri dissociation in patients with multiple sclerosis. J Neuroimaging 27:481–485CrossRef
9.
go back to reference Jokubaitis VG, Spelman T, Kalincik T, Lorscheider J, Havrdova E, Horakova D et al (2016) Predictors of long-term disability accrual in relapse-onset multiple sclerosis. Ann Neurol 80:89–100CrossRef Jokubaitis VG, Spelman T, Kalincik T, Lorscheider J, Havrdova E, Horakova D et al (2016) Predictors of long-term disability accrual in relapse-onset multiple sclerosis. Ann Neurol 80:89–100CrossRef
10.
go back to reference Gajofatto A, Calabrese M, Benedetti MD, Monaco S (2013) Clinical, MRI, and CSF markers of disability progression in multiple sclerosis. Dis Markers 35:687–699CrossRef Gajofatto A, Calabrese M, Benedetti MD, Monaco S (2013) Clinical, MRI, and CSF markers of disability progression in multiple sclerosis. Dis Markers 35:687–699CrossRef
11.
go back to reference Fisniku LK, Brex PA, Altmann DR, Miszkiel KA, Benton CE, Lanyon R et al (2008) Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 131:808–817CrossRef Fisniku LK, Brex PA, Altmann DR, Miszkiel KA, Benton CE, Lanyon R et al (2008) Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 131:808–817CrossRef
12.
go back to reference Wattjes MP, Rovira À, Miller D et al (2015) Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis–establishing disease prognosis and monitoring patients. Nat Rev Neurol 11:597–606PubMed Wattjes MP, Rovira À, Miller D et al (2015) Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis–establishing disease prognosis and monitoring patients. Nat Rev Neurol 11:597–606PubMed
Metadata
Title
Clinico-radiological dissociation of disease activity in MS patients: frequency and clinical relevance
Authors
Nina L. van Faals
Iris Dekker
Lisanne J. Balk
Bastiaan Moraal
Frederik Barkhof
Bernard M. J. Uitdehaag
Joep Killestein
Mike P. Wattjes
Publication date
01-11-2020
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 11/2020
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-020-09991-1

Other articles of this Issue 11/2020

Journal of Neurology 11/2020 Go to the issue